TQL-1055

TQL-1055 is a semi-synthetic analog of the saponin adjuvant QS-21, utilized as an adjuvant in preventive vaccines. It demonstrates potent adjuvant activity with influenza antigens and shows good tolerability when combined with an acellular pertussis vaccine (aP), enhancing anti-pertussis toxin (PT) antibody responses in mice and rabbits. TQL-1055 holds promise for research into chronic Hepatitis B.

C(O[C@H]1[C@H](O[C@H]2[C@H](O)[C@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)CO3)[C@H](C)O2)[C@@H](O)[C@@H](NC(CCCCCCCCCCC(O)=O)=O)[C@@H](CO)O1)(=O)[C@]45[C@](C=6[C@@](C)(C[C@H]4O)[C@@]7(C)[C@](CC6)([C@]8(C)[C@@](CC7)([C@@](C=O)(C)[C@@H](O)CC8)[H])[H])(CC(C)(C)CC5)[H]